Terajima Daiki, Kojima Motohiro, Sakashita Shingo, Taki Tetsuro, Kinoshita Takahiro, Ishii Genichiro, Sakamoto Naoya
Gastric Surgery Division, National Cancer Center Hospital East, Kashiwa, Japan.
Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Kashiwa, Japan.
Gastric Cancer. 2025 Jul 24. doi: 10.1007/s10120-025-01627-5.
Elastic laminal invasion (ELI), defined as tumor invasion beyond the peritoneal elastic lamina, may affect gastric cancer (GC) prognosis, though limited data exist on this relationship.
We retrospectively reviewed representative pathological slides from 396 patients with pT3 or pT4a GC who underwent curative resection to assess the association between ELI and relapse-free survival (RFS) and overall survival (OS).
The 5-year RFS of pT3 GC with negative ELI was 85.9%, which was better than the 55.9% of that of ELI-positive pT3 (P < 0.001) or pT4a (51.3%) GC (P < 0.001). Similarly, the 5-year OS of ELI-negative pT3 GC was 90.4%, while the corresponding values for ELI-positive pT3 and pT4a were 67.0% (P < 0.001) and 63.6% (P < 0.001), respectively. Multivariate analysis revealed that the most significant prognostic factors for RFS were pT factors (i.e., pT3 with ELI/pT4), tumor size (≥ 80 mm), and nodal metastasis. We subdivided our cohort of patients with pathological stage II (pT3N0, pT3N1) GC into ELI-negative and ELI-positive subgroups, and found that the ELI-negative ones had better RFS percentages than those who were ELI-positive or stage III (P = 0.002 and P < 0.001, respectively).
ELI-positive pT3 GC has a worse prognosis than its ELI-negative counterpart, comparable to that of pT4a. These findings suggest a need to revisit the pT grading system in GC.
弹性层浸润(ELI)定义为肿瘤浸润超出腹膜弹性层,可能影响胃癌(GC)的预后,尽管关于这种关系的数据有限。
我们回顾性分析了396例行根治性切除术的pT3或pT4a期胃癌患者的代表性病理切片,以评估ELI与无复发生存期(RFS)和总生存期(OS)之间的关联。
ELI阴性的pT3期胃癌患者5年RFS为85.9%,优于ELI阳性的pT3期(55.9%)或pT4a期(51.3%)胃癌患者(P<0.001)。同样,ELI阴性的pT3期胃癌患者5年OS为90.4%,而ELI阳性的pT3期和pT4a期患者的相应数值分别为67.0%(P<0.001)和63.6%(P<0.001)。多因素分析显示,RFS最重要的预后因素是pT分期(即ELI阳性的pT3期/pT4期)、肿瘤大小(≥80mm)和淋巴结转移。我们将病理分期为II期(pT3N0、pT3N1)的胃癌患者队列分为ELI阴性和ELI阳性亚组,发现ELI阴性患者的RFS百分比高于ELI阳性或III期患者(分别为P=0.002和P<0.001)。
ELI阳性的pT3期胃癌预后比ELI阴性者差,与pT4a期相当。这些发现提示有必要重新审视胃癌的pT分级系统。